Literature DB >> 12781361

PDGF receptors as cancer drug targets.

Kristian Pietras1, Tobias Sjöblom, Kristofer Rubin, Carl-Henrik Heldin, Arne Ostman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12781361     DOI： 10.1016/s1535-6108(03)00089-8

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  135 in total

Review 1.  Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.

Authors:  S A Kono; L E Heasley; R C Doebele; D R Camidge
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

2.  Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor.

Authors:  H Kameda; H Ishigami; M Suzuki; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.

Authors:  Jianying Dong; Jeremy Grunstein; Max Tejada; Frank Peale; Gretchen Frantz; Wei-Ching Liang; Wei Bai; Lanlan Yu; Joe Kowalski; Xiaohuan Liang; Germaine Fuh; Hans-Peter Gerber; Napoleone Ferrara
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

4.  Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase.

Authors:  Camilla Persson; Catrine Sävenhed; Annie Bourdeau; Michel L Tremblay; Boyka Markova; Frank D Böhmer; Fawaz G Haj; Benjamin G Neel; Ari Elson; Carl-Henrik Heldin; Lars Rönnstrand; Arne Ostman; Carina Hellberg
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

Authors:  Tovë M Goldson; Yimei Han; Kristen B Knight; Heidi L Weiss; Vicente A Resto
Journal:  J Exp Ther Oncol       Date:  2010

6.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

7.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

8.  Antiangiogenesis cocktails - stirred or shaken?

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-10-20

Review 9.  Molecular biology of renal cell carcinoma.

Authors:  Begoña Mellado; Pere Gascón
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

10.  Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation.

Authors:  Hagit Dafni; Sun-Jin Kim; James A Bankson; Madhuri Sankaranarayanapillai; Sabrina M Ronen
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.